Ouma co-founder and CEO Dr. Sina Haeri will be presenting at the Society of Maternal-Fetal Medicine's Annual Pregnancy Meeting in San Francisco on February 10, 2023. The presentation is titled "High fetal fraction on cell-free fetal DNA screening: is it associated with adverse perinatal outcomes?"
The study looked at whether having a high amount of fetal DNA in a blood test taken in the first trimester of pregnancy was related to negative pregnancy outcomes. The study included over 20,000 women and found that those with high amounts of fetal DNA were less likely to have certain complications, like gestational diabetes or preterm birth, than those with lower amounts. The study suggests that having high amounts of fetal DNA in the first trimester may actually be a good sign for the pregnancy.
Specific details of the presentation can be found here.
